1. Home
  2. MKSI vs GKOS Comparison

MKSI vs GKOS Comparison

Compare MKSI & GKOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MKSI
  • GKOS
  • Stock Information
  • Founded
  • MKSI 1961
  • GKOS 1998
  • Country
  • MKSI United States
  • GKOS United States
  • Employees
  • MKSI N/A
  • GKOS N/A
  • Industry
  • MKSI Industrial Machinery/Components
  • GKOS Medical/Dental Instruments
  • Sector
  • MKSI Industrials
  • GKOS Health Care
  • Exchange
  • MKSI Nasdaq
  • GKOS Nasdaq
  • Market Cap
  • MKSI 7.1B
  • GKOS 5.8B
  • IPO Year
  • MKSI 1999
  • GKOS 2015
  • Fundamental
  • Price
  • MKSI $100.22
  • GKOS $89.83
  • Analyst Decision
  • MKSI Buy
  • GKOS Strong Buy
  • Analyst Count
  • MKSI 11
  • GKOS 12
  • Target Price
  • MKSI $121.55
  • GKOS $131.17
  • AVG Volume (30 Days)
  • MKSI 1.1M
  • GKOS 1.3M
  • Earning Date
  • MKSI 08-06-2025
  • GKOS 07-30-2025
  • Dividend Yield
  • MKSI 0.88%
  • GKOS N/A
  • EPS Growth
  • MKSI 3206.74
  • GKOS N/A
  • EPS
  • MKSI 3.95
  • GKOS N/A
  • Revenue
  • MKSI $3,741,000,000.00
  • GKOS $432,953,000.00
  • Revenue This Year
  • MKSI $7.17
  • GKOS $27.88
  • Revenue Next Year
  • MKSI $6.66
  • GKOS $27.76
  • P/E Ratio
  • MKSI $25.38
  • GKOS N/A
  • Revenue Growth
  • MKSI 4.50
  • GKOS 26.70
  • 52 Week Low
  • MKSI $54.84
  • GKOS $77.10
  • 52 Week High
  • MKSI $125.33
  • GKOS $163.71
  • Technical
  • Relative Strength Index (RSI)
  • MKSI 51.54
  • GKOS 43.89
  • Support Level
  • MKSI $97.62
  • GKOS $88.94
  • Resistance Level
  • MKSI $106.19
  • GKOS $92.70
  • Average True Range (ATR)
  • MKSI 3.91
  • GKOS 3.82
  • MACD
  • MKSI 0.54
  • GKOS 0.38
  • Stochastic Oscillator
  • MKSI 66.27
  • GKOS 46.71

About MKSI MKS Instruments Inc.

MKS Inc formerly, MKS Instruments Inc is engaged in providing instruments, subsystems, and process control systems used to measure, monitor, deliver, and control parameters of manufacturing processes. The company's product portfolio includes instruments, components, and systems required in manufacturing products such as flat panel displays, medical devices, and electronic materials, among others, used in industrial technologies, semiconductors, life and health sciences, and research and defense markets. The company organizes itself into three reportable business segments: Vacuum Solutions, Photonics Solutions, and Materials Solutions. The Vacuum Solutions segment contributes the majority of the company's revenue.

About GKOS Glaukos Corporation

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases. It has commenced commercialization activities for iDose TR, a first-of-its-kind, long-duration, intracameral procedural pharmaceutical implant designed to continuously deliver glaucoma drug therapy inside the eye for extended periods of time. The company also offer commercially a proprietary bio-activated pharmaceutical therapy for the treatment of a rare corneal disorder, keratoconus. It has three primary commercialized micro-scale surgical device products designed to treat glaucoma: the iStent, the iStent inject W, and the iStent infinite.

Share on Social Networks: